Monument Doses First Patient in MT1988 Psychosis Risk Trial
11 Mar 2026 //
PHARMIWEB
Monument Therapeutics Partners with NIH for MT1988 Trial
19 Aug 2025 //
PR NEWSWIRE
Monument Therapeutics Appoints Robert Radie Chair, Heather Preston
17 Apr 2025 //
PR NEWSWIRE

Market Place
Sourcing Support